For immediate release iSTAR Medical Expands Commercial Rollout with First MINIject Surgeries in Switzerland The only commercially available MIGS device currently targeting the supraciliary
Search jobs Implandata’s EYEMATE System Protects Glaucoma Patients – Even During Lockdown
HANNOVER, Germany, January 18, 2021 / B3C newswire / People with glaucoma and eye doctors face a dilemma. On one hand, patients with glaucoma are
at high risk of losing their eyesight if their disease progresses undetected and essential therapy adjustments are delayed. On the other hand, these typically elderly, vulnerable individuals are often hampered in seeing their doctor for office visits, particularly during a lockdown.
Clinical study: telehealth glaucoma care
Glaucoma specialists and patients welcome the results of the clinical study published in Ophthalmology Glaucoma (1) – they show how Implandata’s EYEMATE system is transforming glaucoma treatment. During a lockdown period, eye specialists remotely monitored the intraocular pressure of their patients. Based on data generated by the EYEMATE system, doctors